Target intelligence / Profile preview

Major Histocompatibility Complex Class I Molecule (MHC Class I)

Target
MHC Class I
Molecular classification
Cell Surface Receptor, Glycoprotein
01

Overview

Major histocompatibility complex (MHC) class I molecules are cell surface glycoproteins found on all nucleated cells and platelets in vertebrates. Their primary function is to present peptide fragments derived from intracellular proteins to cytotoxic T lymphocytes (CTLs), specifically CD8+ T cells, enabling the immune system to monitor cellular health and detect infected or abnormal cells. They are heterodimers composed of a polymorphic heavy α-chain (with three extracellular domains: α1, α2, and α3) and an invariant light chain called beta-2 microglobulin (β2m). The peptide-binding groove is formed by the α1 and α2 domains; it accommodates peptides typically 8–10 amino acids long. The α3 domain interacts with the CD8 co-receptor on cytotoxic T cells. β2-microglobulin stabilizes the structure but does not span the membrane. MHC class I genes correspond to HLA-A, HLA-B, and HLA-C loci within the human leukocyte antigen (HLA) complex. CTLs recognize foreign or abnormal peptides presented by MHC class I. If a CTL's receptor matches both peptide and MHC allele, it triggers apoptosis in target cells displaying non-self antigens such as viral or tumor-derived proteins. Normal expression of self-MHC class I inhibits natural killer (NK) cell activity; Loss or reduction of surface MHC-I can activate NK-mediated killing.

Other names
MHC-IHLA Class IHuman Leukocyte Antigen Class I
02

Mechanism of action

N/A

03

Biological functions

Antigen presentationImmune surveillanceT cell activationNK cell regulation
04

Disease associations

Viral infectionCancerAutoimmune diseaseTransplant rejection
05

Safety considerations

Graft rejection (transplantation)Cytokine storm (immunotherapy)
06

Biomarkers

HLA-A allele typeHLA-B allele typeHLA-C allele typeMHC Class I expression levels

Beyond the preview

Go deeper on Major Histocompatibility Complex Class I Molecule (MHC Class I).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Major Histocompatibility Complex Class I Molecule (MHC Class I).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call